Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015, Medi-Caps has informed regarding extract of Standalone and Consolidated Audited Financial Results for the quarter and year ended on 31st March, 2022 which was approved by the Board in their 01/2022-2023 Board Meeting held on Wednesday, 25th May, 2022 at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (MP) 452001. The company has enclosed the newspaper advertisement published on 27th May, 2022 in Free Press Journal English edition and Choutha Sansar Hindi edition.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: